Cascade Microtech, which provides advanced wafer probe test systems for chip manufacturers, priced 5.3 million shares at $14, above it proposed $11 to $13 price range. The shares offered included 2 million by selling shareholders. Lehman Brothers was the lead underwriter on the deal. Trading is expected to begin on Wednesday under the ticker CSCD on the NASDAQ.
